Conditions by Social Costs


advertisement

Conditions here are listed according to social costs, which are the estimated US dollar costs of the condition. In most cases, the source data refers to the USA or other industrialized nations.

Condition Cost ($) Data
1. Cardiovascular diseases 329.2 billion $329.2 billion with $199.5b direct, $30.9b morbidity, $98.8b mortality (NHLBI 2002)
2. Injury 259 billion estimated $260 billion (IOM)
3. Heart disease 213 billion $214.0 billion with $115.0b direct, $19.0b morbidity, $80.0b mortality (NHLBI 2002)
4. Alcoholism 184 billion $185 billion each year for alcoholism in the US (Mayo Clinic)
5. Occupational Injuries 120 billion more than $121 billion annually (CDC-OC)
6. Lung conditions 115.9 billion $115.9 billion with $65.4b direct, $23.8b morbidity, $26.7b mortality (NHLBI 2002)
7. Coronary heart disease 111.8 billion $111.8 billion with $58.2b direct, $8.4b morbidity, $45.b mortality (NHLBI 2002)
8. Digestive Diseases 106 billion $107 billion in the USA 1992 (Digestive diseases in the United States: Epidemiology and Impact NIH Publication No. 94-1447, 1994)
9. Overweight 99.2 billion $99.2 billion total including direct $51.6 billion and indirect $47.6 billion (NIDDK)
10. Alzheimer's Disease 80 billion $80 to $100 billion in health care expenses and lost wages of both patients and their caregivers (NIA)
11. Stroke 49.4 billion $49.4 billion with $30.8b direct, $5.6b morbidity, $13.0b mortality (NHLBI 2002)
12. Hypertension 47.2 billion $47.2 billion with $34.4b direct, $6.7b morbidity, $6.1bb mortality (NHLBI 2002)
13. Obesity 32 billion $33 billion annually spent on weight-loss products and services (NIDDK)
14. Chronic Obstructive Pulmonary Disease 32.1 billion $32.1 billion with $18.0b direct, $6.8b morbidity, $7.3b mortality (NHLBI 2002)
15. Drug-resistant infectious agents 30 billion as high as $30 billion (NIAID)
16. Congestive Heart Failure 23.2 billion $23.2 billion with $21.4b direct, unavailable morbidity, $1.8b mortality (NHLBI 2002); $3.4 billion was paid by Medicare in 1995 (CDC-OC)
17. End-stage renal disease 22.8 billion $22.8 billion in public and private spending for ESRD program costs in the USA 2001 (United States Renal Data System 2003 Annual Data Report, 2003)
18. Allergies 17 billion $18 billion annually (NIAID)
19. Sexually Transmitted Diseases 17 billion approximately $17 billion including HIV (NIAID)
20. Osteoporosis 17 billion $17 billion in direct expenditure in the USA (National Osteoporosis Foundation, 2004)
21. Medical misadventure 17 billion $17 to $29 billion per year (Institute of Medicine report).
22. Urinary Incontinence 16.3 billion $16.3 billion in the USA 2001 (Obstetrics and Gynecology, 98:398-406, 2001)
23. Arthritis 15.2 billion $15.2 billion annually
24. Asthma 13 billion $14.0 billion with $9.4b direct, $2.7b morbidity, $1.9b mortality (NHLBI 2002)
25. Migraine 12 billion $13 billion in missed work or reduced productivity annually (NINDS)
26. Blood conditions 9.7 billion $9.7 billion with $7.1b direct, $0.7b morbidity, $1.9b mortality (NHLBI 2002)
27. Obsessive-compulsive disorder 8.4 billion $8.4 billion in 1990 in social and economic losses in the USA (NIMH)
28. Pelvic Inflammatory Disease 6 billion estimated $7 billion in 1997 (NIAID)
29. HIV/AIDS 6.7 billion approximately $6.7 billion in 1994 (NIAID)
30. Anemia 6.4 billion $6.4 billion with $4.9b direct, $0.6b morbidity, $0.9b mortality (NHLBI 2002)
31. Peptic Ulcer 5 billion $6 billion annually (DBMD)
32. Sinusitis 5.8 billion more than $5.8 billion in 1996 (NIAID)
33. Chronic Sinusitis 5.8 billion more than $5.8 billion in US health care expenditure (NIAID)
34. Food poisoning 5 billion $5 to $6 billion (NIAID)
35. Nosocomial infections 4.5 billion more than $4.5 billion in 1992 (CDC/NNIS 1992)
36. Human Papillomavirus 3.8 billion estimated $3.8 billion in 1994 (NIAID)
37. Heart failure 3.4 billion $3.4 billion in 1995 in the USA
38. Autism 2 billion more than $3 billion each year in health and educational services (NIMH)
39. Chlamydia 2 billion more than $2 billion
40. Urinary stones 1.8 billion $1.83 billion (direct and indirect) for evaluation and treatment in the USA 1993 (Journal of Urology, 1995)
41. Kidney stones 1.8 billion $1.83 billion was spent on indirectly and directly on the evaluation and treatment of kidney stones in the US 1993 (Weighted Analysis of 1999 NAMCS, 2003, NIDDK)
42. Gonorrhea 1.1 billion almost $1.1 billion (NIAID)
43. Rotavirus 1 billion more than $1 billion in total costs to society including $264 million direct costs (CDC-OC)
44. Chickenpox 918 million estimated $918 million in 1993
45. Cervical Cancer 736 million approximately $737 million
46. Hepatitis C 600 million $600 million (CDC-OC)
47. Group B Streptococcal Infections 293 million $294 million annually in direct medical costs of neonatal disease before prevention (DBMD)
48. Guillain-Barre Syndrome 247 million $247 million to $1.8 billion for Campylobacter induced GBS (NIAID)
49. Genital herpes 237 million approximately $237 million in 1994 (NIAID)
50. Hepatitis A 200 million $200 million in 1991 (CDC-OC)
51. Hepatitis B 156 million $156 million in 1994 (NIAID)
52. Syphilis 106 million estimated $106 million in 1994 (NIAID)
53. Lyme disease 60 million estimated $60 million a year (NIAID)
54. Japanese encephalitis 1 million less than $1 million annually (DVBID)

Medical Tools & Articles:


Next articles:

Medical Articles:
 
 
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise